QIBA Working Meeting

Wednesday, December 4, 2013

 

Agenda

2:30 - 4:00 PM: Plenary Session

Room N136

 

 

Theme: Focus on the following two questions

1.      How is value being defined in contemporary and future healthcare?

2.      How do we estimate the value of quantitative imaging before it is implemented, and measure its value after implementation?

 

 

2:30 2:40 PM Welcome, Background on QIBA, Purpose of Program Daniel Sullivan, QIBA Chair

 

2:40 2:50 PM Overview of Imaging Biomarkers Subcommittee of the Research Committee Board
of the European Society of Radiology

Univ. Prof. Dr. Siegfried Trattnig, Chair

 

2:50 3:00 PM Case for CT Volumetry in CT Screening for Lung Cancer

Presenters include:
James Mulshine, Medical Oncologist, Rush Medical School

David Gierada, Chest Radiologist, Washington University

 

3:00 3:25 PM Emerging Definition of Value in Healthcare Implications for Radiology

Discussants:
Bibb Allen (ACR/Imaging 3.0)

Paul Ellenbogen (ACR Imaging Biomarkers Task Force status)

William Thorwarth (RSNA BOD perspective)
Gail Rodriguez (MITA)

Robert Taylor (Software Industry Executive)

 

3:25 3:50 PM How Can We Measure the Value of QI, Before and After Implementation?

Discussants:

Richard Duszak (CEO ACR HPI)

Ruth Carlos (Health Services Research perspective)

Carolyn Meltzer (RSNA RDC)
Frank Rybicki (Chair, ACR Metrics Committee)

 

3:50 4:00 PM General Discussion (All)

 

4:00 5:00 PM Break Out Sessions:

QIBA CT-VOL N136

QIBA fMRI N127

QIBA PDF-MRI N128

QIBA FDG-PET N137

QIBA COPD/Asthma N134

QIBA US SWS N129